Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept and Celecoxib in Active Ankylosing Spondylitis
NCT01934933Phase 4Completed
- Sponsor
- Sun Yat-sen University
- Start
- Sep 2014
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of etanercept, celecoxib in ankylosing spondylitis (AS), sponsored by Sun Yat-sen University. Started Sep 2014; status: completed.
02
Drugs
etanerceptcelecoxib
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT01934933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01934933.